Welwaze’s mission is to prevent breast cancer deaths. Welwaze Medical developed Celbrea® to support the early detection of breast disease, including breast cancer. Celbrea® is an FDA-cleared Class I medical device that is painless, easy-to-use and in just 15 minutes may alert physicians and patients of a potential underlying breast pathology.